In Vitro Activity of Three Commercial Bacteriophage Cocktails against Multidrug-Resistant Escherichia coli and Proteus spp. Strains of Human and Non-Human Origin

Bernasconi, Odette Joëlle; Donà, Valentina; Tinguely, Regula; Endimiani, Andrea (2017). In Vitro Activity of Three Commercial Bacteriophage Cocktails against Multidrug-Resistant Escherichia coli and Proteus spp. Strains of Human and Non-Human Origin. Journal of global antimicrobial resistance, 8, pp. 179-185. Elsevier 10.1016/j.jgar.2016.12.013

[img]
Preview
Text (Proof corrected in word format)
1-s2.0-S2213716517300255-main.pdf - Accepted Version
Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND).

Download (223kB) | Preview
[img] Text
1-s2.0-S2213716517300255-main.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (354kB) | Request a copy

Background: Bacteriophages could represent a therapeutic alternative to treat infections caused by multidrug-resistant (MDR) pathogens. However, studies analyzing their activity against MDR Enterobacteriaceae are limited. Methods: The in vitro lytic activity of three commercial bacteriophage cocktails (PYO, INTESTI, Septaphage) was evaluated against 70 Escherichia coli and 31 Proteus spp. of human and non-human origin. Isolates were characterized by phenotypic and genotypic methods and included 82 MDR strains: 44 ESBL (of which 15 CTX-M-15-like, including ST131/ST648 E. coli), 27 pAmpC (of which 23 CMY-2-like, including ST131 E. coli), 3 ESBL plus pAmpC, and 8 carbapenemase producers. Phage susceptibility was determined using the spot test. Results: E. coli susceptibility to PYO, INTESTI, and Septaphage was 61%, 67%, and 9%, whereas that of Proteus spp. was 29%, 39%, and 19%, respectively. For the subgroup of ESBL-producing E. coli/Proteus spp., the following susceptible rates were recorded: PYO, 57%; INTESTI, 59%; and Septaphage, 11%. With regard to the pAmpC producers, 59%, 70% and 11% resulted susceptible to PYO, INTESTI, and Septaphage, respectively. Five out of 8 carbapenemase producers and 3 out of 4 colistin-resistant E. coli were susceptible to PYO and INTESTI. Conclusions: This is the first study analyzing the activity of the above three cocktails against well-characterized MDR E. coli and Proteus spp. The overall narrow-spectrum of activity observed could be related to the absence of specific bacteriophages targeting these contemporary MDR strains that are spreading in different settings. Therefore, bacteriophages targeting emerging MDR pathogens need to be isolated and integrated in such bio-preparations.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Service Sector > Institute for Infectious Diseases

Graduate School:

Graduate School for Cellular and Biomedical Sciences (GCB)

UniBE Contributor:

Bernasconi, Odette Joëlle; Donà, Valentina; Tinguely, Regula and Endimiani, Andrea

Subjects:

500 Science > 570 Life sciences; biology
600 Technology > 610 Medicine & health

ISSN:

2213-7165

Publisher:

Elsevier

Funders:

[4] Swiss National Science Foundation

Projects:

[577] SNF project 153377 to Andrea Endimiani

Language:

English

Submitter:

Andrea Endimiani

Date Deposited:

07 Mar 2017 10:50

Last Modified:

22 Feb 2018 02:30

Publisher DOI:

10.1016/j.jgar.2016.12.013

PubMed ID:

28232228

BORIS DOI:

10.7892/boris.92025

URI:

https://boris.unibe.ch/id/eprint/92025

Actions (login required)

Edit item Edit item
Provide Feedback